Recent Updates
Recently added Catalysts

SILVERARC CAPITAL MANAGEMENT, LLC

Track SILVERARC CAPITAL MANAGEMENT, LLC's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Jun 19, 2026
Showing 6 Stocks Out Of 73. Click On The Tickers For More Details
Stock Compnay Name Shares Held Market Value % of Portfolio QoQ Change
CMPX
CMPX
COMPASS THERAPEUTICS INC
859.05 K
4.54 M
0.5
AZYO
AZYO
ELUTIA INC
2.50 M
2.62 M
0.3
ANNX
ANNX
ANNEXON INC
496.46 K
2.75 M
0.3
CAMP
CAMP
CAMP4 THERAPEUTICS CORP
653.59 K
2.88 M
0.3
ABEO
ABEO
ABEONA THERAPEUTICS INC
648.94 K
2.91 M
0.3
null
FULCRUM THERAPEUTICS INC
391.90 K
3.00 M
0.3
API Access

Simple Pricing, Powerful Insights

Full access to Biotech/Pharma investing and trading opportunities.

No hidden fees, powerful insights, tools, and exclusive real time data to maximize your biotech profits.

yearly_arrow
For Visitors

Preview only and discover why serious investors choose our Premium Plan for comprehensive data.

$0.00 / Month

  • Includes 3 day Elite access
For Serious Investor and Traders
Recommended

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $19.00 per Month

Only $24.00/ Month

  • Searchable FDA Calendar with 1000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) score cards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
Market Value

$ 979.78 M

Holdings

73

Period

Q1 2026

Holdings in Top 20

73.8 %

QoQ Changes

36.08 %

Top 20 Holdings